TERRY WHITE CHEMISTS ESOMEPRAZOLE esomeprazole (as magnesium dihydrate) 40mg tablet enteric coated tablet blister pack

Pays: Australie

Langue: anglais

Source: Department of Health (Therapeutic Goods Administration)

Ingrédients actifs:

esomeprazole magnesium dihydrate, Quantity: 43.5 mg (Equivalent: esomeprazole, Qty 40 mg)

Disponible depuis:

Medis Pharma Pty Ltd

DCI (Dénomination commune internationale):

esomeprazole magnesium dihydrate

forme pharmaceutique:

Tablet, enteric coated

Composition:

Excipient Ingredients: triethyl citrate; hypromellose; microcrystalline cellulose; purified talc; sodium stearylfumarate; glyceryl monostearate; polysorbate 80; hyprolose; crospovidone; magnesium stearate; methacrylic acid - ethyl acrylate copolymer (1:1); povidone; macrogol 6000; titanium dioxide; macrogol 400; iron oxide red; iron oxide yellow; maize starch; sucrose

Mode d'administration:

Oral

Unités en paquet:

30, 100, 14, 7

Type d'ordonnance:

(S4) Prescription Only Medicine

indications thérapeutiques:

It is indicated for:,Gastro-Oesophageal Reflux Disease (GORD): treatment of erosive reflux oesophagitis, long-term management of patients with healed oesophagitis to prevent relapse and symptomatic treatment of gastro-oesophageal reflux disease (GORD).,Patients requiring NSAID therapy: short-term treatment of upper gastrointestinal symptoms associated with non-steroidal anti-inflammatory drug NSAID (non-selective and COX-2 selective) therapy, healing of gastric ulcers associated with non-steroidal anti-inflammatory drug NSAID (non-selective and COX-2 selective) therapy and prevention of gastric and duodenal ulcers associated with non-steroidal anti inflammatory drug NSAID (non-selective and COX-2 selective) therapy in patients at risk.,Prevention of rebleeding of gastric or duodenal ulcers following treatment with IV Esomeprazole solution by intravenous infusion (intravenous dosage form can be available from other brands).,Pathological hypersecretory conditions including Zollinger-Ellison syndrome and idiopathic hypersecretion, in combination with appropriate antibiotics for: healing of duodenal ulcer associated with Helicobacter pylori and eradication of Helicobacter pylori in patients with active or healed peptic ulcer.

Descriptif du produit:

Visual Identification: elliptically shaped, biconvex, pink enteric coated tablets; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius

Statut de autorisation:

Licence status A

Date de l'autorisation:

2014-07-30